Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.

Anticancer research - 1 Jan 2000

Nishio Makoto, Taguchi Fumiko, Ohyanagi Fumiyoshi, Horikike Atushi, Ishikawa Yuichi, Satoh Yukitoshi, Okumura Sakae, Nakagawa Ken, Nishio Kazuto, Horai Takeshi

Abstract excerpt

UNLABELLED: The aim of this study was to compare the relationship between HER family expression and clinical response to gefitinib. PATIENTS AND METHODS: Tissues from thirty-one non-small cell lung cancer (NSCLC) patients treated with a monotherapy of gefitinib were analyzed. Expressions of HER family in 31 tumors were examined by immunohistochemistry. RESULTS: The total expressions were 21 for EGFR (68%), 24 for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to ErbB Receptors

Share to Gefitinib

Share to Quinazolines

Share to Receptor Protein-Tyrosine Kinases

Share to Survival Analysis

Source

Identifiers

PMID: 17094398

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancer.PMID 17094398Read ↗

HER family in cancer progression: From discovery to 2020 and beyond.Semantic proximity Read ↗

Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerSemantic proximity Read ↗

Targeting of a novel interplay between MET Tyrosine Kinase and NRF2 enhances sensitivity to Paclitaxel in Triple Negative Breast CancerSemantic proximity Read ↗

The importance of molecular profiling in predicting response to epidermal growth factor receptor family inhibitors in non-small-cell lung cancer: focus on clinical trial results.Semantic proximity Read ↗

[Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].Semantic proximity Read ↗

EGFR mutations in non-small cell lung carcinomas may predict response to gefitinib: extension of an emerging paradigm.Semantic proximity Read ↗

Furmonertinib Activity in NSCLC Harboring EGFR L858R and ERBB2 S310F Co-Mutations: A Case Report With Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.